Table 5.
Associations between PA (in both methods of measurement) and LVEF, and PA and LV mass
Clinical cardiac parameter | PA measurement method | Model | ||||||||
Unadjusted | Limited adjustment | Full adjustment | ||||||||
Effect estimate | 95% CI | P value | Effect estimate | 95% CI | P value | Effect estimate | 95% CI | P value | ||
LVEF | Total MET-min/week | −0.440 | −0.886 to 0.006 | 0.053 | −0.415 | −0.863 to 0.032 | 0.069 | −0.233 | −0.687 to 0.221 | 0.312 |
Seven-day average acceleration | −0.501 | −1.044 to 0.041 | 0.070 | −0.514 | −1.079 to 0.050 | 0.073 | −0.231 | −0.895 to 0.433 | 0.493 | |
LV mass | Total MET-min/week | 1.388 | −0.222 to 2.998 | 0.091 | 0.969 | −0.178 to 2.115 | 0.097 | 1.344 | 0.380 to 2.307 | 0.006 |
Seven-day average acceleration | 2.329 | −0.153 to 4.811 | 0.066 | 2.587 | −0.767 to 4.407 | 0.005 | 3.480 | 1.839 to 5.121 | <0.001 |
Effect estimate reflects an LVEF (in %) or LV mass (in g/m2) change per IQR of either total MET-min/week or 7-day average acceleration.
Effect estimate reflects an LVEF (in %) or LV mass (in g/m2) change per IQR of either total MET-min/week or 7- day average acceleration.
LV, left ventricular; LVEF, LV ejection fraction; MET, metabolic equivalent of task; PA, physical activity.